Viewing Study NCT00736905


Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2025-12-26 @ 1:49 AM
Study NCT ID: NCT00736905
Status: COMPLETED
Last Update Posted: 2010-04-28
First Post: 2008-08-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.
Sponsor: Tibotec Pharmaceuticals, Ireland
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module